Literature DB >> 8204870

Myelodysplastic syndrome after autologous transplantation for lymphoma: the price of progress.

R M Stone.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8204870

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  13 in total

Review 1.  Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia.

Authors:  John G Gribben; Chitra Hosing; David G Maloney
Journal:  Biol Blood Marrow Transplant       Date:  2011-01       Impact factor: 5.742

2.  Early fulminant leukaemia post autologous bone marrow transplantation in non-Hodgkin's lymphoma patients.

Authors:  A Toren; G Rechavi; A Nagler
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

Review 3.  Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors.

Authors:  Smita Bhatia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10       Impact factor: 4.254

Review 4.  Therapy-related myeloid neoplasms - what have we learned so far?

Authors:  Mohammad Faizan Zahid; Aric Parnes; Bipin N Savani; Mark R Litzow; Shahrukh K Hashmi
Journal:  World J Stem Cells       Date:  2016-08-26       Impact factor: 5.326

5.  Therapy-related myelodysplasia and acute myeloid leukemia.

Authors:  Smita Bhatia
Journal:  Semin Oncol       Date:  2013-12       Impact factor: 4.929

6.  Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia.

Authors:  John G Gribben; David Zahrieh; Katherine Stephans; Lini Bartlett-Pandite; Edwin P Alyea; David C Fisher; Arnold S Freedman; Peter Mauch; Robert Schlossman; Lecia V Sequist; Robert J Soiffer; Blossom Marshall; Donna Neuberg; Jerome Ritz; Lee M Nadler
Journal:  Blood       Date:  2005-08-30       Impact factor: 22.113

Review 7.  Important features of myelodysplastic syndrome.

Authors:  Wolf K Hofmann; H Phillip Koeffler
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 8.  Genetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.

Authors:  Smita Bhatia
Journal:  Cancer       Date:  2014-10-29       Impact factor: 6.860

Review 9.  Subsequent malignant neoplasms after hematopoietic cell transplantation.

Authors:  Gerard Socié; K Scott Baker; Smita Bhatia
Journal:  Biol Blood Marrow Transplant       Date:  2012-01       Impact factor: 5.742

Review 10.  Cyclophosphamide and cancer: golden anniversary.

Authors:  Ashkan Emadi; Richard J Jones; Robert A Brodsky
Journal:  Nat Rev Clin Oncol       Date:  2009-09-29       Impact factor: 66.675
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.